Citius Pharmaceuticals Inc (CTXR)

04:01 AM

What analysts say about Citius Pharmaceuticals Inc. stockFree Market Dynamics Reports - Autocar Professional

04:01 AM

Jul 24, 2025

Citius Pharmaceuticals Inc. Stock Analysis and ForecastLightning-fast growth - Autocar Professional

Jul 24, 2025

Jul 24, 2025

Citius Oncology Announces Closing of $9.0 Million Public Offering - StreetInsider

Jul 24, 2025

Jul 24, 2025

What drives Citius Pharmaceuticals Inc. stock priceSuperior risk-adjusted returns - jammulinksnews.com

Jul 24, 2025

Jul 23, 2025

Is Citius Pharmaceuticals Inc. a good long term investmentFree Stock Market Knowledge Sharing - Autocar Professional

Jul 23, 2025

Jul 17, 2025

Citius Oncology closes $9 million public offering to support LYMPHIR - Investing.com Australia

Jul 17, 2025

Jul 17, 2025

Citius Oncology closes $9 million public offering to support LYMPHIR By Investing.com - Investing.com Nigeria

Jul 17, 2025

Jul 17, 2025

Citius Oncology Raises $9M in Public Offering for LYMPHIR Commercialization - AInvest

Jul 17, 2025

Jul 17, 2025

Citius Oncology Announces Pricing Of $9M "Reasonable Best-Efforts" Public Offering Of 6,818,182 Shares Of Common Stock And Warrants To Purchase Shares Of Common Stock At A Public Offering Price Of $1.32 Per Share - 富途牛牛

Jul 17, 2025

Jul 17, 2025

Cencora distribution deal boosts Citius shares - MSN

Jul 17, 2025

Jul 16, 2025

Citius Pharmaceuticals shares fall 1.34% after-hours following Citius Oncology's public offering. - AInvest

Jul 16, 2025

Jul 16, 2025

Citius Oncology Announces Pricing of $9.0 Million Public Offering - Finansavisen

Jul 16, 2025

Jul 15, 2025

Citius Oncology (CTOR): Is LYMPHIR's Launch Priced for Success? - AInvest

Jul 15, 2025

Jul 15, 2025

Citius Oncology: Is A Lymphir Launch Coming Too Late? - Seeking Alpha

Jul 15, 2025

Jul 15, 2025

Citius Pharmaceuticals (CTXR) Surges on New Distribution Deal - GuruFocus

Jul 15, 2025

Jul 15, 2025

Citius Oncology stock rises after expanding LYMPHIR distribution network By Investing.com - Investing.com Nigeria

Jul 15, 2025

Jul 15, 2025

Citius Oncology stock rises after expanding LYMPHIR distribution network - Investing.com Australia

Jul 15, 2025

Jul 15, 2025

Citius Oncology Expands Lymphir Distribution With Cencora - MarketScreener

Jul 15, 2025

Jul 15, 2025

Citius Oncology expands distribution network for LYMPHIR with Cencora - Investing.com Australia

Jul 15, 2025

Jul 15, 2025

Citius Oncology expands distribution network for LYMPHIR with Cencora By Investing.com - Investing.com Canada

Jul 15, 2025

Jul 15, 2025

Citius stock gains on Cencora distribution deal (CTXR:NASDAQ) - Seeking Alpha

Jul 15, 2025

Jul 15, 2025

Pre-market Movers: KAPA, CYCC, SONN, RANI... - RTTNews

Jul 15, 2025

Jul 15, 2025

Citius Oncology Expands Distribution Network for LYMPHIR with Execution of Distribution Services Agreement with Cencora - WV News

Jul 15, 2025

Jul 15, 2025

Citius Pharmaceuticals Soars 10.18% on Nasdaq Compliance - AInvest

Jul 15, 2025

Jul 14, 2025

Citius Pharmaceuticals' Strategic Financing: Balancing Dilution Risks with LYMPHIR's Commercial Potential - AInvest

Jul 14, 2025

Jul 14, 2025

Citius Oncology Plans Stock Offering; Shares Down - MarketScreener

Jul 14, 2025

Jul 11, 2025

Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) On The Verge Of Breaking Even - simplywall.st

Jul 11, 2025

Jul 10, 2025

Citius Pharmaceuticals regains Nasdaq compliance - MSN

Jul 10, 2025

Jul 09, 2025

Citius Pharmaceuticals Regains Nasdaq Compliance - The Globe and Mail

Jul 09, 2025

Jul 08, 2025

CTXR SEC FilingsCitius Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Jul 08, 2025